Showing results (211-220 of 464) with videos related to

Sort By:
Pageof 47
Current Drug Targets|January 7, 2014
Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunitiesBo Hong, A Pieter J van den Heuvel, Varun V Prabhu, et al.
Oncotarget|October 22, 2021
Hyperprogression of a mismatch repair-deficient colon cancer in a humanized mouse model following administration of immune checkpoint inhibitor pembrolizumabIlyas Sahin, Andrew George, Shengliang Zhang, et al.
American Journal of Cancer Research|February 10, 2022
Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profilesKelsey E Huntington, Anna Louie, Lanlan Zhou, et al.
Human Vaccines & Immunotherapeutics|May 21, 2021
Strategies to sensitize cancer cells to immunotherapyAndrew George, Ilyas Sahin, Benedito A Carneiro, et al.
Cancer Research|March 14, 2001
Global effects of anchorage on gene expression during mammary carcinoma cell growth reveal role of tumor necrosis factor-related apoptosis-inducing ligand in anoikisG S Goldberg, Z Jin, H Ichikawa, et al.
Cancer Research|December 5, 2000
The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligandN Ozoren, K Kim, T F Burns, et al.
Scientific Reports|August 31, 2017
P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targetingPrashanth Gokare, Niklas K Finnberg, Phillip H Abbosh, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
Neuroendocrine Prostate Cancer Drivers SOX2 and BRN2 Confer Differential Responses to Imipridones ONC201, ONC206, and ONC212 in Prostate Cancer Cell LinesConnor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
The Journal of Biological Chemistry|April 18, 2003
BRCA1 augments transcription by the NF-kappaB transcription factor by binding to the Rel domain of the p65/RelA subunitMiriam Benezra, Nathalie Chevallier, Debra J Morrison, et al.
American Journal of Cancer Research|February 10, 2022
miR-3132 upregulates surface TRAIL to induce apoptotic cell death in cancer cellsAmriti R Lulla, Yan Zhou, Marie D Ralff, et al.
Pageof 47